会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Imidazoline derivatives for systemic combating of ectoparasites in host
animals
    • 用于动物体内生物体系化合物的咪唑啉衍生物
    • US5128361A
    • 1992-07-07
    • US452799
    • 1989-12-18
    • Herbert StarkGerhard SalbeckWerner Bonin
    • Herbert StarkGerhard SalbeckWerner Bonin
    • A61K31/415A61P33/00C07D233/20C07D233/22C07D233/24
    • C07D233/20C07D233/22C07D233/24
    • The present invention relates to agents for systemic combating of ectoperasites in host animals, containing a compound of the formul I ##STR1## in which R.sup.1 denotes hydrogen, (C.sub.1 -C.sub.5)-alkyl, (C.sub.1 -C.sub.3)-halogenoalkyl or halogen;R.sup.2 and R.sup.3 independently of one another denote (c.sub.1 -C.sub.5)-alkyl, (C.sub.2 -C.sub.5)-alkenyl, (C.sub.2 -C.sub.5)-alkynyl, (C.sub.3 -C.sub.7)-cycloalkyl, (C.sub.3 -C.sub.7)-cycloalkenyl, (C.sub.1 -C.sub.3)-halogenoalkyl, halogen, cyano, nitro, (C.sub.1 -C.sub.5)-alkoxy, (C.sub.1 -C.sub.3)-alkoxy-C.sub.1 -C.sub.3)-alkyl, (C.sub.1 -C.sub.3)-halogenoalkoxy or (C.sub.1 -C.sub.3)-alkylthio, or R.sup.2 and R.sup.3 together form a polymethylene chain having 2 to 5 carbon atoms:R.sup.4 denotes hydrogen, (c.sub.1 -C.sub.10)-alkyl, (C.sub.2 -C.sub.5)-alkenyl or (C.sub.3 -C.sub.7)-cycloalkyl;R.sup.5 denotes hydrogen, (C.sub.1 -C.sub.10)-alkyl, (C.sub.3 -C.sub.5)-alkenyl, C.sub.3 -C.sub.5)-alkynyl, (C.sub.3 -C.sub.7)- cycloalkyl, (C.sub.3 -C.sub.7)-cycloalkenyl, (C.sub.1 -C.sub.3)-halogenoalkyl or (C.sub.1 -C.sub.3)-alkoxy-(C hd 1-C.sub.3)-alkyl;X denotes oxygen, sulfur or an --NR.sup.6 --group; andR.sup.6 denotes hydrogen, (C.sub.1 -C.sub.5)-alkyl, (C.sub.3 -C.sub.5)-alkenyl, C.sub.3 -C.sub.5)-alkynyl, (C.sub.3 -C.sub.7)-cycloalkyl, C.sub.3 -C.sub.7)-cycloalkenyl, (C.sub.1 -C.sub.3)-halogenoalkyl or (C.sub.1 -C.sub.3)-alkoxy-(C.sub.1 -C.sub.3)-alkyl,or biologically tolerated acid addition salts thereof.The compounds of the formulas I are novel in some cases and are likewise included in the invention.
    • 本发明涉及用于在宿主动物体内全身性对抗异位子的药剂,其含有式I(I)的化合物,其中R 1表示氢,(C 1 -C 5) - 烷基,(C 1 -C 3) - 卤代烷基或 卤素; (C 1 -C 5) - 链烯基,(C 2 -C 5) - 炔基,(C 3 -C 7) - 环烷基,(C 3 -C 7) - 环烯基,(C 1 -C 5) (C 1 -C 3) - 烷氧基,(C 1 -C 3) - 烷氧基-C 1 -C 3) - 烷基,(C 1 -C 3) - 卤代烷氧基或(C 1 -C 3) - 烷硫基 或者R 2和R 3一起形成具有2至5个碳原子的多亚甲基链:R 4表示氢,(C 1 -C 10) - 烷基,(C 2 -C 5) - 烯基或(C 3 -C 7) - 环烷基; R5表示氢,(C1-C10) - 烷基,(C3-C5) - 烯基,C3-C5) - 炔基,(C3-C7) - 环烷基,(C3-C7) - 环烯基,(C1-C3) - 卤代烷基 或(C 1 -C 3) - 烷氧基 - (C 1 H 11 - C 3) - 烷基; X表示氧,硫或-NR 6 - 基; 并且R 6表示氢,(C 1 -C 5) - 烷基,(C 3 -C 5) - 烯基,C 3 -C 5) - 炔基,(C 3 -C 7) - 环烷基,C 3 -C 7) - 环烯基,(C 1 -C 3) - 卤代烷基 或(C 1 -C 3) - 烷氧基 - (C 1 -C 3) - 烷基或其生物耐受的酸加成盐。 式I的化合物在一些情况下是新的,并且同样包括在本发明中。